Herzliya, Israel and Calgary, Alberta – (May 17, 2022) – Innocan Pharma Corporation (CSE: INNO)
(FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan”) is pleased to announce that it has filed and
obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) with the
securities regulatory authorities in each of the provinces and territories of Canada…